Remove topic viewpoints
article thumbnail

The Evolution of Media in Medical Education: Introducing HSS Viewpoint

PM360

We will be introducing HSS Viewpoint in September 2022 to facilitate dialogue and fill in the gap when one-on-one conversations fall short. People trust written words and HSS Viewpoint will only improve the level of trust toward Healio Strategic Solutions,” said Thomas M. Cavallaro VP, Creative Marketing, Healio Strategic Solutions.

article thumbnail

Our 10 (OK, 11) Favorite Sales Influencers of 2020

Integrity Solutions

Many sales influencers are doing great things, but we wanted to shine a spotlight on a few of our favorites, those whose viewpoints align well with ours and can help motivate you and your teams to perform better in 2020. . by Will Milano.

Sales 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

[Podcast] COVID Disruption & Its Indelible Mark on Healthcare Marketing

Healthcare Success

With more than 20 years of experience working in the hospital space, I asked Alan to share his informed viewpoint on the economic impact COVID has had on health systems. “I Both Alan and I have covered COVID-related topics on our blogs. I guarantee most hospitals and healthcare systems are not getting rich. What Does That Mean?

article thumbnail

Aggressive Selling: The High-Stakes Game of Push and Profit

Contrarian Sales Techniques

Aggressive selling, a strategy as old as commerce itself, continues to be a hotly debated topic. Businesses that can master this balance may lead the way in a more consumer-friendly sales environment. As the marketplace continues to evolve, so too must our approaches to selling and buying.

Ethics 40
article thumbnail

A glance back to Pharma Integrates, London 2022 – part iii

pharmaphorum

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. How do we bridge the value of death between a great scientific idea, a potential therapeutic, and an industry?

Pharma 81